Clinical and pathologic predictors of outcome in Thymoma-Associated myasthenia gravis
- 1 November 2003
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (5) , 1643-1649
- https://doi.org/10.1016/s0003-4975(03)01139-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Classification of thymic epithelial neoplasms: a controversial issue coming to an end?Journal of Cellular and Molecular Medicine, 2001
- Malignant thymoma: current status and future directionsCancer Treatment Reviews, 2000
- Thymoma: A multivariate analysis of factors predicting survivalThe Annals of Thoracic Surgery, 1995
- Evaluation of a histogenetic classification for thymic epithelial tumoursHistopathology, 1994
- Myasthenia GravisNew England Journal of Medicine, 1994
- The Pathological Basis of Thymoma‐associated Myasthenia GravisAnnals of the New York Academy of Sciences, 1993
- Analysis of prognostic factors and clinicopathological staging of thymomaThe Annals of Thoracic Surgery, 1990
- Clinical Characteristics and Prognosis of Myasthenia Gravis with Other Autoimmune DiseasesThe Annals of Thoracic Surgery, 1986
- Myasthenia Gravis with Thymoma: Analysis of and Postoperative Prognosis for 65 Patients with Thymomatous Myasthenia GravisThe Annals of Thoracic Surgery, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVISThe Lancet, 1984